Growing geriatric population and rising prevalence of brain tumour are key driving factors for growth of brain tumor diagnosis and treatment market across the globe.

As per a report published by the WHO in the year 2012, over 14 million people were diagnosed with brain tumour. Also, 8.2 million deaths were caused due to the tumour.  Furthermore, it is stated that morbidity rate is anticipated to increase by approximately 70% in next two decades.

Likewise, as per a report published by the Global Health Observatory (GHO) in the year 2015,it is clearly mentioned that the number of caused due to cancer is likely to increase by 44.0% by 2030.

The market for treatment of brain tumour is likely to grow proportionally with rising incidence of brain tumour and increasing death rate over the forecast period. Various government bodies such as International Brain Tumor Alliance, the WHO, and American Brain Tumor Association have come together for research of treatment to cure the disease.

On the basis of therapeutics, the market has been bifurcated into chemotherapy, immunotherapy, radiation therapy, targeted therapy, and surgery. Surgery is anticipated to be leading contributing segment to the brain tumour and diagnosis and treatment market, in terms of revenue. The dominance of the segment is attributed to low awareness level and less diagnostics options. As a result, the disease gets aggravated to grade IV stage. Further, the trend is likely to continue in coming years as well.

Moreover, radiation therapy segment is anticipated to exhibit substantial growth rate in forthcoming years. The therapy uses gamma rays, x-rays, or protons to kill the cancer cell. 

Global Brain Tumor Diagnosis and Treatments Market: Snapshot

The demand in the global market for brain tumor diagnosis and treatments is anticipated to increase at a potent CAGR of 8.5% during the forecast period of 2017 to 2025. The prosperity of this market is primarily a reflection of innovations in drug delivery to brain cancer cells, increasing prevalence of brain cancer, rising aging population, and growing incidences of cancer via chemical exposure. On the other hand, exponentially high cost of diagnostic as well as treatment is the most prominent hindrance over this market. The global for brain tumor diagnosis and treatments market was worth US$406.0 mn in 2016, and is estimated to reach a valuation of US$840.7 mn by the end of the forecast period, which is 2025.

brain tumor treatment market

CT-Scan Remains High-Demand Diagnosis Segment

Based on product-type, the global brain tumor diagnosis and treatments market has been segmented into primary brain tumor and secondary brain tumor. The primary brain tumor segment, which accounted for 74.7% of the overall demand in 2016, has been sub-segmented into common tumors such as meningioma, astrocytomas, gliomas, and pituitary tumors. Along all sub-segments, meningioma continues to be most prevalent across the world, including Asia Pacific and Europe. It has been observed that in these two regions, CNS and brain tumors are the third most common cancer among young adults and juveniles, causing most of the cancer-related deaths in this age group. The report projects the segment of primary brain tumor to witness an incrementing demand at CAGR of 8.7% during the forecast period from 2017 to 2025.

On the basis of diagnosis type, the global brain tumor diagnosis and treatments market has been bifurcated into CT-Scan, MRI, Molecular Testing, PET-CT Scan, and EEG, with the former accounting for more than 35% share of global market in 2016. It has been noted that CT-Scan remain the most preferred choice of brain cancer diagnosis, owing to their ability to effectively differentiate between bone masses and elaborate soft tissues, besides offering the option to click 3D images in a series at multiple angle. In addition to that, upcoming technological advancements in innovative mobile CT-Scan devices are also expected to aid to the growth of the CT-Scan diagnosis segment during the forecast period. Treatment-wise, surgery category has remained the most preferable primary treatment for brain tumor. It has identified as the first and the only treatment for most type of the brain tumors. That being said, radiation therapy is projected for a strong growth rate during forecast period of 2017 to 2025, a result of growing awareness regarding noninvasive novel treatment due to technological advancements.

Europe Projected for the Best Growth Rate

In 2016, North America accounted for the most prominent share of the demand for brain tumor diagnosis and treatments. The U.S. dominated the brain tumor diagnosis and treatments market in North America, serving about 89.3% share in of North America market in 2016. This dominance is essentially due to the factors such as large number of people diagnosed with brain tumor, extensive research and development activities, technological advancements, and increasing healthcare awareness about the treatment and management of brain tumor are driving market growth. On the other hand, Europe is projected for the best CAGR among all regions during the forecast period, gaining substantial demand from the countries of Germany and The U.K. Rising prevalence of brain tumors disease, escalating percentage of geriatrics among the European population, and government’s initiative regarding growing awareness of advanced technologies are some of the key factors driving the brain tumor diagnosis and treatments market in Europe.

Pfizer, Inc., Toshiba Medical Systems, GE Healthcare, AstraZeneca, Merck & Co., Inc., Siemens Healthineers, Carestream Health, Hitachi Medical Corporation, Philips Healthcare, and Shimadzu Corporation are some of the key companies currently operating in the global brain tumor diagnosis and treatments market.

Global Brain Tumor Diagnosis and Treatments Market: Overview

This report on brain tumor diagnosis and treatments market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of brain tumor diagnosis and treatments as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global brain tumor diagnosis and treatments market with respect to the leading market segments based on major products type segment, diagnosis type, treatment type and geographies.

Global Brain Tumor Diagnosis and Treatments Market: Segmentation

Based on the product type, the brain tumor diagnosis and treatments market has been segmented into: primary brain tumors (meningioma, gliomas, astrocytomas, pituitary tumors and others) and secondary brain tumors. Each of the market segments have been extensively analyzed based on the market related factors such as increasing rate of brain tumors incidences worldwide, technological advancement, and growing number of use of brain tumor diagnosis and treatments  in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Brain Tumor Diagnosis and Treatments Market: Key Research Aspects

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the brain tumor diagnosis and treatments market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global Brain Tumor Diagnosis and Treatments market.

Geographically, brain tumor diagnosis and treatments market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, value chain analysis, and heat map analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global brain tumor diagnosis and treatments market.

Global Brain Tumor Diagnosis and Treatments Market: Competitive Landscape

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global brain tumor diagnosis and treatments market.

The report also profiles key players operating in the brain tumor diagnosis and treatments market which are AstraZeneca, Carestream Health, GE Healthcare, Hitachi Medical Corporation, Merck & Co., Inc., Philips Healthcare, Pfizer, Inc., Shimadzu Corporation, Siemens Healthineers, Toshiba Medical Systems Corporation and other prominent players.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global brain tumor diagnosis and treatments market is segmented as follows:

by Product Type

  • Primary Brain Tumor
    • Meningioma
    • Gliomas
    • Astrocytomas
    • Pituitary Tumors
    • Others
  • Secondary Brain Tumor

by Product Analysis

  • Stains & Varnishes
  • Shellacs
  • Lacquers
  • Others

by Diagnosis Type

  • CT Scan
  • MRI
  • PET-CT Scan
  • Molecular Testing
  • EEG
  • Others

by Treatment Type

  • Surgery
  • Radiation Therapy
  • Targeted Therapy
  • Chemotherapy
  • Immunotherapy

by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • U.K.
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface 
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology 

3. Executive Summary : Global Brain Tumor Diagnosis and Treatment Market

4. Market Overview
     4.1. Introduction 
            4.1.1. Product Overview
            4.1.2. Key Industry Events
     4.2. Market Dynamics 
            4.2.1. Drivers
            4.2.2. Restraints
            4.2.3. Opportunity
     4.3. Porter’s Five Forces Analysis
     4.4. Value Chain Analysis
     4.5. Market Outlook 

5. Global Brain Tumor Diagnosis and Treatments Market Analysis and Forecasts, By Product Type
     5.1. Key Findings / Developments
     5.2. Introduction & Definition
     5.3. Market Value Forecast By Product Type , 2017-2025
            5.3.1. Primary Brain Tumor
                     5.3.1.1. Meningioma
                     5.3.1.2. Gliomas
                     5.3.1.3. Astrocytomas
                     5.3.1.4. Pituitary Tumors
                     5.3.1.5. Others
            5.3.2. Secondary Brain Tumor
     5.4. Key Trends 
     5.5. Market Attractiveness By Product Type

6. Global Brain Tumor Diagnosis and Treatments Market Analysis and Forecasts, By Diagnosis Type
     6.1. Key Findings / Developments
     6.2. Introduction & Definition
     6.3. Market Value Forecast By Diagnosis Type, 2017–2025
            6.3.1. CT Scan
            6.3.2. MRI
            6.3.3. PET-CT Scan
            6.3.4. Molecular Testing
            6.3.5. EEG
            6.3.6. Others
     6.4. Key Trends 
     6.5. Market Attractiveness By Diagnosis Type

7. Global Brain Tumor Diagnosis and Treatments Market Analysis and Forecasts, By Treatment Type
     7.1. Key Findings / Developments
     7.2. Introduction & Definition
     7.3. Market Value Forecast By Treatment Type, 2017–2025
            7.3.1. Surgery
            7.3.2. Radiation Therapy
            7.3.3. Targeted Therapy
            7.3.4. Chemotherapy
            7.3.5. Immunotherapy
     7.4. Key Trends 
     7.5. Market Attractiveness By Diagnosis Type

8. Global Brain Tumor Diagnosis and Treatments Market Analysis and Forecasts, by Region
     8.1. Policies and Regulations 
     8.2. Market Value Forecast By Region 
            8.2.1. North America
            8.2.2. Europe
            8.2.3. Asia Pacific
            8.2.4. Latin America
            8.2.5. Middle East & Africa
     8.3. Market Attractiveness Analysis By Region 

9. North America Brain Tumor Diagnosis and Treatments Market Analysis and Forecast
     9.1. Market Value Forecast By Country, 2017-2025
            9.1.1. U.S.
            9.1.2. Canada
     9.2. Market Value Forecast By Product Type 
     9.3. Market Value Forecast By Diagnosis Type 
     9.4. Market Value Forecast By Treatment Type 
     9.5. Market Attractiveness Analysis 
            9.5.1. By Country
            9.5.2. By Product Type
            9.5.3. By Diagnosis Type
            9.5.4. By Treatment Type

10. Europe Brain Tumor Diagnosis and Treatments Analysis and Forecast
     10.1. Market Value Forecast By Country, 2017-2025
            10.1.1. Germany
            10.1.2. Spain
            10.1.3. France
            10.1.4. U.K.
            10.1.5. Italy
            10.1.6. Rest of Europe
     10.2. Market Value Forecast By Product Type 
     10.3. Market Value Forecast By Diagnosis Type 
     10.4. Market Value Forecast By Treatment Type 
     10.5. Market Attractiveness Analysis 
            10.5.1. By Country
            10.5.2. By Product Type
            10.5.3. By Diagnosis Type
            10.5.4. By Treatment Type

11. Asia Pacific Brain Tumor Diagnosis and Treatments Analysis and Forecast
     11.1. Market Value Forecast By Country, 2017-2025
            11.1.1. China
            11.1.2. India
            11.1.3. Japan
            11.1.4. Rest of Asia Pacific
     11.2. Market Value Forecast By Product Type 
     11.3. Market Value Forecast By Diagnosis Type 
     11.4. Market Value Forecast By Treatment Type 
     11.5. Market Attractiveness Analysis 
            11.5.1. By Country
            11.5.2. By Product Type
            11.5.3. By Diagnosis Type
            11.5.4. By Treatment Type

12. Latin America Brain Tumor Diagnosis and Treatments Analysis and Forecast
     12.1. Market Value Forecast By Country, 2017-2025
            12.1.1. Brazil
            12.1.2. Mexico
            12.1.3. Rest of Latin America
     12.2. Market Value Forecast By Product Type 
     12.3. Market Value Forecast By Diagnosis Type 
     12.4. Market Value Forecast By Treatment Type 
     12.5. Market Attractiveness Analysis 
            12.5.1. By Country
            12.5.2. By Product Type
            12.5.3. By Diagnosis Type
            12.5.4. By Treatment Type

13. Middle East and Africa Brain Tumor Diagnosis and Treatments Analysis and Forecast
     13.1. Market Value Forecast By Country, 2017-2025
            13.1.1. South Africa
            13.1.2. Saudi Arabia
            13.1.3. Rest of Middle East and Africa
     13.2. Market Value Forecast By Product Type 
     13.3. Market Value Forecast By Diagnosis Type 
     13.4. Market Value Forecast By Treatment Type 
     13.5. Market Attractiveness Analysis 
            13.5.1. By Country
            13.5.2. By Product Type
            13.5.3. By Diagnosis Type
            13.5.4. By Treatment Type

14. Competition Landscape
     14.1. Heat Map Analysis By Company (2016)
     14.2. Competition Matrix
     14.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy )
            14.3.1. AstraZeneca
                     14.3.1.1. Company Details
                     14.3.1.2. Business Overview
                     14.3.1.3. Financial Overview
                     14.3.1.4. Strategic Overview
                     14.3.1.5. SWOT Analysis
                     14.3.1.6. Recent Development
            14.3.2. Carestream Health
                     14.3.2.1. Company Details
                     14.3.2.2. Business Overview
                     14.3.2.3. Financial Overview
                     14.3.2.4. Strategic Overview
                     14.3.2.5. SWOT Analysis
                     14.3.2.6. Recent Development
            14.3.3. GE Healthcare
                     14.3.3.1. Company Details
                     14.3.3.2. Business Overview
                     14.3.3.3. Financial Overview
                     14.3.3.4. Strategic Overview
                     14.3.3.5. SWOT Analysis
                     14.3.3.6. Recent Development
            14.3.4. Hitachi Medical Corporation 
                     14.3.4.1. Company Details
                     14.3.4.2. Business Overview
                     14.3.4.3. Financial Overview
                     14.3.4.4. Strategic Overview
                     14.3.4.5. SWOT Analysis
                     14.3.4.6. Recent Development
            14.3.5. Merck & Co., Inc.
                     14.3.5.1. Company Details
                     14.3.5.2. Business Overview
                     14.3.5.3. Financial Overview
                     14.3.5.4. Strategic Overview
                     14.3.5.5. SWOT Analysis
                     14.3.5.6. Recent Development
            14.3.6. Philips Healthcare
                     14.3.6.1. Company Details
                     14.3.6.2. Business Overview
                     14.3.6.3. Financial Overview
                     14.3.6.4. Strategic Overview
                     14.3.6.5. SWOT Analysis
                     14.3.6.6. Recent Development
            14.3.7. Pfizer, Inc. 
                     14.3.7.1. Company Details
                     14.3.7.2. Business Overview
                     14.3.7.3. Financial Overview
                     14.3.7.4. Strategic Overview
                     14.3.7.5. SWOT Analysis
                     14.3.7.6. Recent Development
            14.3.8. Shimadzu Corporation 
                     14.3.8.1. Company Details
                     14.3.8.2. Business Overview
                     14.3.8.3. Financial Overview
                     14.3.8.4. Strategic Overview
                     14.3.8.5. SWOT Analysis
                     14.3.8.6. Recent Development
            14.3.9. Siemens Healthineers
                     14.3.9.1. Company Details
                     14.3.9.2. Business Overview
                     14.3.9.3. Financial Overview
                     14.3.9.4. Strategic Overview
                     14.3.9.5. SWOT Analysis
                     14.3.9.6. Recent Development
            14.3.10. Toshiba Medical System Corporation
                     14.3.10.1. Company Details
                     14.3.10.2. Business Overview
                     14.3.10.3. Financial Overview
                     14.3.10.4. Strategic Overview
                     14.3.10.5. SWOT Analysis
                     14.3.10.6. Recent Development

List of Tables 

TABLE 1 Global Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Product Type, 2017–2025
TABLE 2 Global Primary Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Product Type, 2017–2025
TABLE 3 Global Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 4 Global Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
TABLE 5 Global Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Region, 2017–2025
TABLE 6 North America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 7 North America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Product Type, 2017–2025
TABLE 8 North America Primary Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Product Type, 2017–2025
TABLE 9 North America Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Diagnosis Type, 2017–2025
TABLE 10 North America Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Treatment Type, 2017–2025
TABLE 11 Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 12 Europe Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 13 Europe Primary Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 14 Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 15 Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
TABLE 16 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 17 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 18 Asia Pacific Primary Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 19 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 20 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
TABLE 21 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 22 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 23 Latin America Primary Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 24 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 25 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
TABLE 26 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 27 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 28 Middle East & Africa Primary Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 29 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 30 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025

 

List of Figures

FIG. 1 Global Brain Tumor Diagnosis and Therapeutics Market Size (US$ Mn) and Forecast, 2016–2025
FIG. 2 Brain Tumor Diagnosis and Treatment Market Value share, by Product Type (2016)
FIG. 3 Brain Tumor Diagnosis and Treatment Market Value share, by Diagnosis Type (2016)
FIG. 4 Brain Tumor Diagnosis and Treatment Market Value share, by Treatment Type (2016)
FIG. 5 Brain Tumor Diagnosis and Treatment Market Value share, by Region (2016)
FIG. 6 Global Brain Tumor Diagnosis and Treatment Market Value Share Analysis, by Product Type, 2016 and 2025
FIG. 7 Global Primary Brain Tumor Diagnosis and Treatment Market Value Share Analysis, by Product Type, 2016 and 2025
FIG. 8 Global Primary Brain Tumor Diagnosis and Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
FIG. 9 Global Secondary Brain Tumor Diagnosis and Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
FIG. 10 Global Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 11 Global Brain Tumor Diagnosis and Treatment Market Value Share Analysis, by Diagnosis Type, 2016 and 2025
FIG. 12 Global CT Scan Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 13 Global MRI Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 14 Global PET-CT Scan Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 15 Global Molecular Testing Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 16 Global EEG Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 17 Global Others Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 18 Global Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 19 Global Brain Tumor Diagnosis and Treatment Market Value Share Analysis, by Treatment Type, 2016 and 2025
FIG. 20 Global Surgery Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 21 Global Radiation Therapy Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 22 Global Targeted Therapy Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 23 Global Chemotherapy Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 24 Global Immunotherapy Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 25 Global Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 26 North America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 27 Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 28 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 29 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 30 MEA Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 31 Global Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Region
FIG. 32 U.S. Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 33 Canada Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 34 North America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 35 North America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 36 North America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 37 North America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 38 Germany Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 39 Spain Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 40 France Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 41 U.K. Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 42 Italy Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 43 Rest of Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 44 Europe Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 45 Europe Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 46 Europe Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 47 Europe Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 48 China Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 49 India Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 50 Japan Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 51 Rest of APAC Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 52 Asia Pacific Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 53 Asia Pacific Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 54 Asia Pacific Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 55 Asia Pacific Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 56 Brazil Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 57 Mexico Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 58 Rest of LATAM Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 59 Latin America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 60 Latin America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 61 Latin America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 62 Latin America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 63 South Africa Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 64 Saudi Arabia Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 65 Rest of MEA Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 66 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 67 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 68 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 69 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 70 Figure 70: Heat Map Analysis By Company (2016)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Brain Tumor Treatment Market